These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 38293445)

  • 1. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baroreflex activation therapy in patients with heart failure and reduced ejection fraction.
    Cordero Pereda D; de Rueda Panadero C; de Juan Bagudá J; Gómez Bueno M; Robles-Mezcua A; Álvarez-García J
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):342-344. PubMed ID: 37981190
    [No Abstract]   [Full Text] [Related]  

  • 3. Baroreflex activation therapy for heart failure with reduced ejection fraction: A comprehensive systematic review and meta-analysis.
    Shi R; Sun T; Wang M; Xiang Q; Ding Y; Yin S; Chen Y; Shen L; Yu P; Chen X
    Heliyon; 2024 Jan; 10(2):e24177. PubMed ID: 38293445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review.
    Schmidt R; Rodrigues CG; Schmidt KH; Irigoyen MCC
    ESC Heart Fail; 2020 Feb; 7(1):3-14. PubMed ID: 31965746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Bhattacharjee P; Khan Z
    Cureus; 2023 Nov; 15(11):e48674. PubMed ID: 38090453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review.
    Molina-Linde JM; Cordero-Pereda D; Baños-Álvarez E; Rosario-Lozano MP; Blasco-Amaro JA
    ESC Heart Fail; 2023 Oct; 10(5):2760-2772. PubMed ID: 37522644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis.
    Xiang Q; Wang M; Ding Y; Fan M; Tong H; Chen J; Yu P; Shen L; Chen X
    Front Pharmacol; 2022; 13():832782. PubMed ID: 35444529
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy.
    Nottebohm PI; Dumitrescu D; Hamacher S; Hohmann C; Madershahian N; Baldus S; Reuter H; Halbach M
    Ther Adv Cardiovasc Dis; 2022; 16():17539447221131203. PubMed ID: 36305639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure.
    Giannoni A; Gentile F; Buoncristiani F; Borrelli C; Sciarrone P; Spiesshoefer J; Bramanti F; Iudice G; Javaheri S; Emdin M; Passino C
    JACC Heart Fail; 2022 Sep; 10(9):662-676. PubMed ID: 36049816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baroreflex activation therapy in heart failure: targeting the right patient.
    Gentile F; Passino C; Emdin M; Giannoni A
    Eur J Heart Fail; 2022 Sep; 24(9):1674-1676. PubMed ID: 35851979
    [No Abstract]   [Full Text] [Related]  

  • 12. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
    Coats AJS; Abraham WT; Zile MR; Lindenfeld JA; Weaver FA; Fudim M; Bauersachs J; Duval S; Galle E; Zannad F
    Eur J Heart Fail; 2022 Sep; 24(9):1665-1673. PubMed ID: 35713888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
    McDonagh TA; Metra M; Adamo M; Gardner RS; Baumbach A; Böhm M; Burri H; Butler J; Čelutkienė J; Chioncel O; Cleland JGF; Coats AJS; Crespo-Leiro MG; Farmakis D; Gilard M; Heymans S; Hoes AW; Jaarsma T; Jankowska EA; Lainscak M; Lam CSP; Lyon AR; McMurray JJV; Mebazaa A; Mindham R; Muneretto C; Piepoli MF; Price S; Rosano GMC; Ruschitzka F; Skibelund AK;
    Rev Esp Cardiol (Engl Ed); 2022 Jun; 75(6):523. PubMed ID: 35636830
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.